» Drug Discovery through AI: OPM and Servier launch FederAidd, an international virtual campus for open innovation MyPharma Editions

Posted on Thursday, December 15, 2022

Oncodesign Precision Medicine (OPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancers, and Servier, an international pharmaceutical group, announce the creation of FederAidd (Federation for Artificial Intelligence in Drug Discovery), an international virtual campus for open innovation whose objective is to make the drug discovery (or Drug Discovery “DD”) process more reliable and faster thanks to Artificial Intelligence (AI).

OPM and Servier are the founding members of FederAidd and announce the launch of this new collaborative space with InterSystems France, which is the first member of the campus. Publisher of innovative technologies, InterSystems is a leading player in the management of health data whose mission is to support organizations in their digital transformation.

Philippe Genne, Chief Executive Officer of Oncodesign Precision Medicine, declares: “The arrival of new disruptive technologies in the hands of those skilled in the art always gives rise to a phase of reciprocal observation and misunderstanding before everyone finds their permanent marks. The potential of AI in the field of Drug Discovery is immense, research programs generate flows of data often resulting from multidisciplinary skills, their overall analysis is made complex by the quality and heterogeneity of the data. FederAidd’s purpose is to allow the realization of Drug Discovery projects, with the aim of discovering new active drugs in pathologies without therapeutic solution, in contact with the best experts and the latest developments in AI. AI is a constantly evolving technology, proximity and exchange are essential within a private and public network collaborating on projects. This campus should make it possible to respond to these issues of knowledge and discovery. »

FederAidd’s main objective is to foster between its members AI projects applied to the discovery of innovative drugs and responding to unmet medical needs. Some FederAidd members will have expertise in Drug Discovery, and their projects can be accelerated and enhanced through the use of AI. Other FederAidd members will have AI skills and know-how, and help improve and accelerate Drug Discovery projects.

FederAidd also offers a corpus of collective intelligence, based on a collaborative platform, which makes it possible to pool the tools and knowledge shared by the partners within the virtual campus.

FederAidd thus offers its members a space for experimentation, training, reflection and promotes exchanges and the creation of value within drug discovery or entrepreneurship projects.

Olivier Nosjean, Director of Open Innovation and Scientific Affairs at Servier, comments: “We are very happy to launch FederAidd with our long-standing partner OPM. This virtual campus of open innovation aims to bring together different players in the health ecosystem from around the world, such as academic groups, biotechs, start-ups or pharmaceutical groups, in order to stimulate the discovery of new treatments, and accelerate therapeutic innovation through artificial intelligence. »

In addition, a Call for Expression of Interest (AMI) will be launched in 2023, in consultation with Medicen, the health competitiveness cluster of the Île-de-France Region, and Montreal International (Canada), in order to identify new partnerships around innovative projects, in France and abroad, which could benefit from the support of FederAidd. Medicen, Montreal International and the Bourgogne-Franche-Comté region support FederAidd, which responds to needs observed within their ecosystems.

Launched between Dijon and Paris-Saclay, France, and Montreal, Canada, the campus will welcome members and health actors from all over the world.

A webinar will take place in the first quarter of 2023 to share all the information relating to how FederAidd works and how to join the international virtual campus. Dedicated communication will be made on the social networks of the founding members in January.

Source : OPM / servant

We want to say thanks to the author of this post for this remarkable material

» Drug Discovery through AI: OPM and Servier launch FederAidd, an international virtual campus for open innovation MyPharma Editions


Take a look at our social media profiles as well as other pages related to themhttps://www.ai-magazine.com/related-pages/